Alliance Management Co-op
Beam Therapeutics
Alliance Management Co-op
Beam Therapeutics
Develops base editing–based precision medicines
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a highly talented and motivated Alliance Management Co-op to join our Alliance Management team working on Alliance Management activities as part of the Business Development group, from January through June 2027. The Alliance Management Co-op will be a key contributor in maintaining strategic alliances at Beam, including foundational licenses, collaborations, and enabling licenses. This person will contribute to the operational excellence in alliance management through the development and implementation of strategic continuous improvement initiatives within Alliance Management and in collaboration with various functional areas. This role will add capabilities aimed at ensuring that Beam has productive and successful alliances that support our company strategy and mission.
Responsibilities:
Qualifications:
Hourly pay will will be determined based on several factors, including but not limited to, relevant experience, skills, and education.
Co-op Hourly Pay Range 30 - 37 USD
Develops base editing–based precision medicines
Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.
Explore more opportunities at Beam Therapeutics